QTRX vs SMTI
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is QTRX is a StrongBuy and SMTI is a Buy.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
QTRX’s FA Score shows that 0 FA rating(s) are green whileSMTI’s FA Score has 0 green FA rating(s).
- QTRX’s FA Score: 0 green, 5 red.
- SMTI’s FA Score: 0 green, 5 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
QTRX’s TA Score shows that 5 TA indicator(s) are bullish while SMTI’s TA Score has 5 bullish TA indicator(s).
- QTRX’s TA Score: 5 bullish, 4 bearish.
- SMTI’s TA Score: 5 bullish, 3 bearish.
Price Growth
QTRX (@Medical Specialties) experienced а +6.92% price change this week, while SMTI (@Medical Specialties) price change was +3.23% for the same time period.
The average weekly price growth across all stocks in the @Medical Specialties industry was +5.76%. For the same industry, the average monthly price growth was +7.52%, and the average quarterly price growth was +0.65%.
Reported Earning Dates
QTRX is expected to report earnings on Nov 06, 2024.
SMTI is expected to report earnings on Nov 11, 2024.
Industries' Descriptions
@Medical Specialties (+5.76% weekly)Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.
| QTRX | SMTI | QTRX / SMTI | |
| Capitalization | 908M | 319M | 285% |
| EBITDA | -39.79M | -289.09K | 13,762% |
| Gain YTD | -53.109 | -16.107 | 330% |
| P/E Ratio | N/A | N/A | - |
| Revenue | 121M | 65M | 186% |
| Total Cash | 321M | 5.15M | 6,237% |
| Total Debt | 41.5M | 11.8M | 352% |
QTRX | SMTI | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 13 | 31 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 35 Fair valued | 70 Overvalued | |
PROFIT vs RISK RATING 1..100 | 100 | 41 | |
SMR RATING 1..100 | 93 | 94 | |
PRICE GROWTH RATING 1..100 | 63 | 50 | |
P/E GROWTH RATING 1..100 | 100 | 100 | |
SEASONALITY SCORE 1..100 | n/a | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
QTRX's Valuation (35) in the Pharmaceuticals Major industry is somewhat better than the same rating for SMTI (70) in the null industry. This means that QTRX’s stock grew somewhat faster than SMTI’s over the last 12 months.
SMTI's Profit vs Risk Rating (41) in the null industry is somewhat better than the same rating for QTRX (100) in the Pharmaceuticals Major industry. This means that SMTI’s stock grew somewhat faster than QTRX’s over the last 12 months.
QTRX's SMR Rating (93) in the Pharmaceuticals Major industry is in the same range as SMTI (94) in the null industry. This means that QTRX’s stock grew similarly to SMTI’s over the last 12 months.
SMTI's Price Growth Rating (50) in the null industry is in the same range as QTRX (63) in the Pharmaceuticals Major industry. This means that SMTI’s stock grew similarly to QTRX’s over the last 12 months.
SMTI's P/E Growth Rating (100) in the null industry is in the same range as QTRX (100) in the Pharmaceuticals Major industry. This means that SMTI’s stock grew similarly to QTRX’s over the last 12 months.
| QTRX | SMTI | |
|---|---|---|
| RSI ODDS (%) | 4 days ago 75% | N/A |
| Stochastic ODDS (%) | 4 days ago 85% | 4 days ago 90% |
| Momentum ODDS (%) | 4 days ago 81% | 4 days ago 71% |
| MACD ODDS (%) | 4 days ago 90% | 4 days ago 76% |
| TrendWeek ODDS (%) | 4 days ago 83% | 4 days ago 83% |
| TrendMonth ODDS (%) | 4 days ago 81% | 4 days ago 83% |
| Advances ODDS (%) | 4 days ago 82% | 5 days ago 82% |
| Declines ODDS (%) | 11 days ago 82% | 21 days ago 78% |
| BollingerBands ODDS (%) | 6 days ago 90% | N/A |
| Aroon ODDS (%) | 4 days ago 86% | 4 days ago 82% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| CUURX | 52.26 | 1.22 | +2.39% |
| Columbia Small Cap Value I Inst2 | |||
| HCAYX | 57.24 | 0.51 | +0.90% |
| Hartford Capital Appreciation Y | |||
| BRIIX | 16.49 | 0.14 | +0.86% |
| Baron Real Estate Income Institutional | |||
| SHPCX | 14.53 | 0.07 | +0.48% |
| Saratoga Health & Biotechnology C | |||
| MXIGX | 13.90 | 0.03 | +0.22% |
| Empower International Growth Inv | |||
QTRX and
Correlation & Price change
A.I.dvisor indicates that over the last year, QTRX has been loosely correlated with LUNG. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if QTRX jumps, then LUNG could also see price increases.
| Ticker / NAME | Correlation To QTRX | 1D Price Change % | ||
|---|---|---|---|---|
| QTRX | 100% | +2.64% | ||
| LUNG - QTRX | 50% Loosely correlated | +1.59% | ||
| SIBN - QTRX | 44% Loosely correlated | +2.41% | ||
| KIDS - QTRX | 44% Loosely correlated | +2.15% | ||
| BLFS - QTRX | 43% Loosely correlated | +3.46% | ||
| MASS - QTRX | 42% Loosely correlated | +3.75% | ||
More | ||||
SMTI and
Correlation & Price change
A.I.dvisor indicates that over the last year, SMTI has been loosely correlated with IQV. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if SMTI jumps, then IQV could also see price increases.
| Ticker / NAME | Correlation To SMTI | 1D Price Change % | ||
|---|---|---|---|---|
| SMTI | 100% | -0.58% | ||
| IQV - SMTI | 40% Loosely correlated | +0.13% | ||
| AZTA - SMTI | 40% Loosely correlated | +3.41% | ||
| IDXX - SMTI | 38% Loosely correlated | +0.71% | ||
| QTRX - SMTI | 37% Loosely correlated | +2.64% | ||
| BLFS - SMTI | 36% Loosely correlated | +3.46% | ||
More | ||||